ENANTA PHARMACEUTICALS INC — 8-K Filings
107 8-K filings on record
This page lists all 8-K filings submitted to the SEC by ENANTA PHARMACEUTICALS INC (ENTA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ENANTA PHARMACEUTICALS INC has filed 107 8-K documents with the SEC since 2002. To view all SEC filings by ENANTA PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
EFFECT
NT 10-Q
POSASR
REGDEX
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-125113 | Mar 26, 2026 | Mar 20, 2026 |
| 8-K | 8-K | 0001193125-26-104109 | Mar 12, 2026 | Mar 11, 2026 |
| 8-K | 8-K | 0001193125-26-042812 | Feb 9, 2026 | — |
| 8-K | 8-K | 0001193125-25-284633 | Nov 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-226828 | Oct 1, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-221527 | Sep 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-221791 | Sep 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-189691 | Aug 27, 2025 | Aug 26, 2025 |
| 8-K | 8-K | 0001193125-25-183719 | Aug 20, 2025 | — |
| 8-K | 8-K | 0001193125-25-177941 | Aug 11, 2025 | — |
| 8-K | 8-K | 0000950170-25-069155 | May 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-040230 | Mar 17, 2025 | Mar 13, 2025 |
| 8-K | 8-K | 0000950170-25-017035 | Feb 10, 2025 | — |
| 8-K | 8-K | 0001193125-24-272936 | Dec 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-130553 | Nov 25, 2024 | — |
| 8-K | 8-K | 0000950170-24-090722 | Aug 5, 2024 | — |
| 8-K | 8-K | 0000950170-24-053532 | May 6, 2024 | — |
| 8-K | 8-K | 0000950170-24-029889 | Mar 12, 2024 | Mar 6, 2024 |
| 8-K | 8-K | 0000950170-24-012186 | Feb 7, 2024 | — |
| 8-K | 8-K | 0001193125-23-303014 | Dec 26, 2023 | Dec 19, 2023 |
| 8-K | 8-K | 0000950170-23-065087 | Nov 20, 2023 | — |
| 8-K | 8-K | 0000950170-23-039051 | Aug 7, 2023 | — |
| 8-K | 8-K | 0000950170-23-026739 | Jun 7, 2023 | — |
| 8-K | 8-K | 0000950170-23-018788 | May 8, 2023 | — |
| 8-K | 8-K | 0001193125-23-122434 | Apr 27, 2023 | Apr 25, 2023 |
| 8-K | 8-K | 0000950170-23-007317 | Mar 10, 2023 | — |
| 8-K | 8-K | 0000950170-23-006453 | Mar 7, 2023 | Mar 2, 2023 |
| 8-K | 8-K | 0000950170-23-001981 | Feb 7, 2023 | — |
| 8-K | 8-K | 0000950170-22-025532 | Nov 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-231310 | Aug 26, 2022 | — |
| 8-K | 8-K | 0000950170-22-015505 | Aug 8, 2022 | — |
| 8-K | 8-K | 0001193125-22-178106 | Jun 22, 2022 | Jun 21, 2022 |
| 8-K | 8-K | 0001193125-22-153071 | May 17, 2022 | May 12, 2022 |
| 8-K | 8-K | 0000950170-22-008469 | May 9, 2022 | — |
| 8-K | 8-K | 0000950170-22-003221 | Mar 9, 2022 | Mar 3, 2022 |
| 8-K | 8-K | 0000950170-22-003118 | Mar 8, 2022 | Mar 3, 2022 |
| 8-K | 8-K | 0000950170-22-000875 | Feb 8, 2022 | — |
| 8-K | 8-K | 0000950170-21-004845 | Nov 22, 2021 | — |
| 8-K | 8-K HATA DIRECTOR | 0001564590-21-045408 | Aug 23, 2021 | Aug 19, 2021 |
| 8-K | 8-K | 0001564590-21-041571 | Aug 5, 2021 | — |
| 8-K | 8-K NATHALIE ADDA RETIREMENT | 0001564590-21-036895 | Jul 16, 2021 | Jul 14, 2021 |
| 8-K | 8-K Q2 2021 EARNINGS RELEASE | 0001564590-21-024938 | May 6, 2021 | — |
| 8-K | 8-K PROXY VOTE | 0001564590-21-011253 | Mar 5, 2021 | Mar 2, 2021 |
| 8-K | 8-K | 0001564590-21-004686 | Feb 8, 2021 | — |
| 8-K | 8-K ABBVIE 8.01 OTHER EVENTS | 0001564590-21-004518 | Feb 5, 2021 | — |
| 8-K | 8-K | 0001564590-20-056183 | Dec 4, 2020 | Dec 1, 2020 |
| 8-K | 8-K Q4 2020 | 0001564590-20-054888 | Nov 23, 2020 | — |
| 8-K | 8-K | 0001564590-20-036125 | Aug 4, 2020 | — |
| 8-K | 8-K NEW DIRECTOR - MARK FOLETTA | 0001564590-20-031261 | Jun 30, 2020 | Jun 29, 2020 |
| 8-K | 8-K Q2 2020 EARNINGS RELEASE | 0001564590-20-021925 | May 6, 2020 | — |